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ABSTRACT 
THE ROLE OF G-PROTEIN COUPLED ESTROGEN RECEPTOR (GPER/GPR30) IN 
HIPPOCAMPAL MEMORY AND CELL SIGNALING IN FEMALE MICE 
 
by 
Jae Kyoon Kim 
 
The University of Wisconsin-Milwaukee, 2014  
Under the Supervision of Professor Karyn Frick 
 
The loss of estrogens at menopause significantly increases a woman’s risk of memory 
loss and Alzheimer’s disease because estrogens are essential trophic factors for the 
hippocampus. However, current hormone replacement therapies are not recommended 
to reduce age-related memory decline because of their adverse side effects. To 
develop better hormone replacement therapies, it is essential to understand the 
mechanisms through which estrogens regulate memory. Our laboratory has 
demonstrated that the ability of 17β-estradiol (E2) to enhance hippocampal memory 
depends on the rapid activation of extracellular-signal-regulated kinase (ERK), which 
occurs through activation of ERα and ERβ. The G-protein coupled estrogen receptor 
(GPER) is a novel membrane estrogen receptor, expressed in areas of the brain 
important for learning and memory such as the hippocampus. However, little is 
known about the role of dorsal hippocampal (DH) GPER in hippocampal memory 
consolidation and cell signaling. Here, the present study tested the roles of GPER in 
regulating hippocampal memory consolidation and cell signaling in young female 
mice. DH infusion of the GPER agonist, G-1, enhanced object recognition and spatial 
memory consolidation in ovariectomized female mice. DH infusion of the GPER 
antagonist, G-15, blocked the memory-enhancing effects of G-1, suggesting that 
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GPER activation mimics the beneficial effects of E2 on hippocampal memory. 
Interestingly, however, G-1 did not increase ERK phosphorylation like E2, but instead 
significantly increased phosphorylation of the c-Jun N-terminal kinase (JNK) in the 
DH, suggesting that the molecular mechanisms underlying the memory-enhancing 
effects of GPER activation may differ from those of ERα and ERβ activation. 
Consistent with this notion, DH infusion of the JNK inhibitor, SP600125, blocked G-
1-induced memory enhancement and JNK phosphorylation, whereas the ERK 
inhibitor, U0126, did not. Finally, we showed that DH infusion of SP600125 or G-15 
did not prevent E2 from enhancing memory and activating ERK, demonstrating that 
the memory-enhancing effects of E2 are not dependent on JNK or GPER activation in 
the DH. These results indicate that GPER regulates memory independently from ERα 
and ERβ by activating JNK signaling, rather than ERK signaling. Together, the data 
suggest that GPER does not function as an estrogen receptor in the DH. As such, this 
study identifies GPER as a putative new target for reducing memory decline in 
menopausal women without the detrimental side effects of currently available 
treatment options 
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Introduction 
 The massive loss of estrogens at menopause significantly increases the risk of 
memory deficiency and Alzheimer’s disease (AD) in women (Zandi et al., 2002; Yaffe 
et al., 2007). Out of the 5.2 million Alzheimer’s disease patients, 3.4 million are 
women (Alzheimer's Association, 2012), and this number will continue to increase 
due to the aging of the baby boomer generation. In 2012, the costs of patient care for 
AD and other dementias is estimated at $200 billion and are projected to rise to $1.1 
trillion by 2050 (Alzheimer's Association, 2012). Estrogen therapies can decrease the 
risk of menopause-related memory decline and AD in women (Yaffe et al., 1998; 
Zandi et al., 2002), however these treatments are accompanied by increased risk of 
breast cancer, heart disease, and stroke (Rossouw et al., 2002). The effects of 
estrogens in the hippocampus are important to study because hippocampus 
dysfunction leads to memory loss (deToledo-Morrell et al., 1988). Unfortunately, the 
mechanisms underlying the beneficial effects of estrogens on memory are not fully 
understood. These beneficial effects may be mediated by intracellular estrogen 
receptors (ERα and ERβ) or membrane-bound ERs (e.g., G-protein coupled estrogen 
receptor; GPER) (Waters et al., 2011). Although some evidence suggests an important 
role of intracellular ERs (ERα and ERβ) in memory formation (Liu et al., 2008; Frick 
et al., 2010b; Boulware et al., 2013), very little is known regarding the role of GPER 
in hippocampal memory consolidation.  
 This gap in our knowledge is important to address because manipulating 
GPER could provide the memory-enhancing effects of intracellular ER activation 
without cancerous side effects, as ERα and ERβ activation are implicated in certain 
types of cancer (Deroo and Korach, 2006; Burns and Korach, 2012). Whereas nuclear 
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ERα and ERβ expression increased or stayed constant during breast cancer 
progression (Filardo et al., 2006), GPER expression decreased, and other evidence 
suggests that GPER acts independently from ERα and ERβ in cancer cell lines 
(Filardo and Thomas, 2012). Furthermore, GPER activation suppresses cell 
proliferation in ovarian cancer cell lines (Ignatov et al., 2013). Therefore, 
understanding the role of GPER in estrogen signaling may help resolve some of the 
controversies related to estrogen’s involvement in regulating both cognitive function 
and certain types of cancer. Moreover, better understanding of GPER function could 
also provide important opportunities for the development of new therapies that would 
provide the cognitive benefits of estrogens while limiting potentially dangerous side 
effects. 
 
Hippocampus 
 The hippocampus is one of the most researched structures in the brain. It is a 
bilateral medial temporal lobe structure that plays a central role in the functioning of 
the limbic system, due to its connections with the temporal cortex (e.g., entorhinal, 
perirhinal, and parahippocampal cortices), septum, and amygdala (Arushanyan and 
Beier, 2008). The primary cell type within the hippocampus is the pyramidal neuron, 
which are organized into a form of three-layered cortical tissue. The hippocampus in 
subdivided into several subregions, denoted as CA1, CA2, CA3, and dentate gyrus, 
based on morphologic and functional composition. Although the specific functions of 
the hippocampus remain subject to debate, most investigators agree that the 
hippocampus plays a critical role in learning and memory.  
 The famous case study of patient H.M, firstly published by Brenda Milner, 
first suggested the critical importance of the hippocampus for memory formation 
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(Scoville and Milner, 1957). After surgery of a bilateral medial temporal lobectomy, 
H.M. had severely impaired memory, although not all types of memory were affected. 
H.M. experienced severely impaired declarative memory; H.M. had severe 
anterograde amnesia as well as partial retrograde amnesia, on the other hand, His 
nondeclarative memory and short-term memory was preserved (Corkin et al., 1997). 
Therefore, H.M. study demonstrated the organization of memory in the brain, long 
term memory and immediate memory and the findings from H.M. motivated the 
efforts to study the neurobiological mechanisms underlying memory formation in 
animal models, such as monkey and rodent models (Squire, 2009). Two of the most 
well-known functions of the hippocampus are the generation of cognitive maps for 
use in spatial navigation and regulating episodic memory processes (Smith and 
Mizumori, 2006).  Analysis of neuronal activity, by recordings of single neurons in 
the hippocampus, revealed that the hippocampus is involved in spatial navigation, as 
well as other abilities including detecting speed and direction of movement, match or 
non-match detection, and olfactory discrimination (Holscher, 2003).  
 To test functioning of hippocampus in rodent models, many behavioral tests 
have been established. For example, spatial learning and memory can be evaluated 
using several different methods, including the Morris water maze, Barnes maze, radial 
arm maze, T-maze, and Y-maze (Yuede et al., 2007). Our laboratory uses object 
recognition and object placement tasks to test hippocampal- dependent object 
recognition memory and spatial memory because these one-trail tasks allow us to link 
memory consolidation with rapid molecular events within the hippocampus. 
Moreover, these tasks can be conducted using the same apparatus and training 
procedures, permitting observation of multiple forms of hippocampal memory under 
similar testing conditions.    
４ 
 
 
 
 
Object recognition (OR) and object placement (OP) 
 OR and OP have ben used extensively to examine hippocampal memory in 
rodents because they are sensitive to numerous factors, including hormones, aging, 
and drug treatments (Tuscher et al., 2014). Although the tasks can be run with 
anywhere from 2-6 objects, most protocols for rodents typically require them to 
explore two identical objects in a testing arena. During the training phase, these two 
objects are usually identical.  For object recognition, memory is tested after a delay 
by allowing subjects to explore one familiar object that is identical to the training 
objects and one novel object. Mice who remember the familiar object will spend more 
time than chance exploring the novel object. For object placement, memory is tested 
by moving one of the familiar training objects to a new location in the arena. Mice 
who remember the training object locations will spend more time than chance 
exploring the moved object. 
 Both OR and OP are well suited for investigating hormonal regulation of 
hippocampal memory because these tasks take advantage of rodent's instinct, 
attraction to novel stimuli, without other potential variables influencing motivation. 
For example, the Morris water maze involves the stress of submersion in water and 
dry land mazes like the radial arm maze, T-maze, and Y-maze involve the stress of 
nutrient restriction. These stressors can induce physiological changes, including 
hormone level changes that can differ between males and females (ter Horst et al., 
2012). In contrast, OR and OP involve only the subject’s own intrinsic motivation to 
explore; it uses no nutrient restriction, provides no rewards, and it does not place 
subjects in an uncomfortable stressful environment (i.e., no water submersion, shock, 
or exposure to bright light). Therefore, OR and OP are ideal behavior tasks for 
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studying the effects of hormone treatment on learning and memory. Despite some 
controversy surrounding the role of the hippocampus in object recognition, several 
studies demonstrate the importance of the hippocampus in regulating object 
recognition (Clark et al., 2000; Broadbent et al., 2004). In fact, one recent study 
suggests that inactivation of a very small portion of the total hippocampus can impair 
object recognition memory (Cohen et al., 2013). Furthermore, ovariectomy impairs 
memory in both OR and OP (Wallace et al., 2006), and as will be demonstrated below, 
estrogen treatment enhances OR and OP memory consolidation.  
 
Estrogen effects on the hippocampus  
 Estrogens are a class of sex steroid hormones that are synthesized primarily 
within the ovaries and placenta, although smaller amounts of estrogens are also 
synthesized in non-gonadal organs such as the heart, liver, bone, and muscle (Cui et 
al., 2013). Estrogens influence many physiological processes via estrogen receptors 
(ERs), including reproduction, bone integrity, cognition, and parenting behaviors. The 
three major forms of estrogens are estrone (E1), estradiol (E2), and estriol (E3). Of 
these, E2 is most potent and biologically active. E2 levels in the rat hippocampus are 
higher than in serum (Hojo et al., 2004), implying an important role of estrogens in 
the hippocampus. The earliest findings to demonstrate that E2 regulates hippocampal 
function showed that dendritic spine density in the CA1 region in the female rat 
hippocampus is elevated when estrogen levels are their highest during the estrous 
cycle and that E2 treatment reverses an ovariectomy-induced decrease in CA1 spine 
synapse density (Gould et al., 1990; Woolley et al., 1990). Exogenous E2 also 
increases hippocampal neurogenesis and enhances various forms of hippocampal 
synaptic plasticity, including long-term potentiation (Foy et al., 1999; McClure et al., 
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2013). In general, estrogens have been shown to enhance hippocampal memory in 
menopausal women and female rodents (Duff and Hampson, 2000; Frick, 2009). 
Many studies have demonstrated that exogenous E2 administration enhances 
hippocampal memory using a variety of tasks, including the Morris water maze, radial 
arm maze, and T-maze (Bimonte and Denenberg, 1999; Daniel and Dohanich, 2001; 
Wide et al., 2004; Bohacek and Daniel, 2007). As discussed below and in our recent 
review (Tuscher et al., 2014), E2 facilitates memory consolidation in the OR and OP 
tasks as well. However, the molecular mechanisms underlying this enhancement are 
not well understood.  
 Using an ovariectomized mouse model, our laboratory previously 
demonstrated that post-training bilateral infusion of E2 into the dorsal hippocampus 
(DH) enhances hippocampal-dependent memory consolidation in the OR task 
(Fernandez et al., 2008). Other work from our lab has shown that DH E2 infusions 
also enhance hippocampal-dependent spatial memory in OP (Boulware et al., 2013). 
Although the role of the hippocampus in OR has been subject to debate (Gervais et al., 
2013), DH lesions or inactivations demonstrate that the DH is essential for object 
recognition memory consolidation in rats and mice (Clark et al., 2000; Baker and Kim, 
2002; Fernandez et al., 2008; Cohen et al., 2013). In our laboratory, E2 is infused 
immediately after training in OR and OP, rather than before training, to pinpoint E2’s 
effects on memory consolidation without affecting motivation, anxiety, or encoding 
during training. Infusion of E2 three hours after training does not enhance memory 
consolidation (Fernandez et al., 2008), suggesting that E2-induced hippocampal 
memory consolidation occurs within three hours of training. Vehicle-infused young 
ovariectomized mice show a significant preference for the novel object 24 hr, but not 
48 hr, after OR training. However, E2-infused mice exhibit enhanced memory 48 hr 
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after OR training, as indicated by their spending significantly more time than chance 
with the novel object. For the OP task, vehicle-infused young ovariectomized mice 
show a significant preference for the moved object 4 hr, but not 24 hr, after OP 
training. However, E2-infused mice exhibit a significant preference for the moved 
object 24 hr after OP training. Thus, to test the memory-enhancing effects of drugs, 
we use a 48-hr retention delay for OR and a 24-hr delay for OP. To test the memory-
impairing effects of drugs, we use a 24-hr delay for OR and a 4-hr delay for OP.  
 Our laboratory has extensively studied the molecular mechanisms through 
which E2 affects hippocampal memory (Harburger et al., 2007; Lewis et al., 2008; 
Pechenino and Frick, 2009; Fan et al., 2010; Frick et al., 2010a; Zhao et al., 2010; 
Zhao et al., 2012; Boulware et al., 2013; Fortress et al., 2013b; Fortress et al., 2013a; 
Fortress et al., 2014). In particular, we have shown repeatedly that phosphorylation of 
the p42 isoform of the cell signaling kinase extracellular signal regulated kinase (ERK) 
in the DH is necessary for E2 to enhance OR memory (Fernandez et al., 2008; Fan et 
al., 2010; Zhao et al., 2010; Zhao et al., 2012). This activation is observed as early as 
five minutes after DH infusion of E2. The importance of ERK in mediating the 
mnemonic effects of E2 was underscored by other work from our laboratory showing 
that rapid activation of the p42 isoform of ERK (p42-ERK) is required for histone 
acetylation alterations that promote the transcriptional events that enhance memory 
consolidation (Zhao et al., 2010). Although this work sheds light on the intracellular 
events that underlie the memory-enhancing effects of E2, the ERs that mediate these 
effects have remained somewhat of a mystery. 
 
Estrogen receptors 
 Two types of ERs, intracellular ERs (ERα and ERβ) and membrane ERs (e.g., 
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GPER, ER-X) likely mediate the memory-enhancing effects of E2. The intracellular 
ERs, ERα and ERβ, have been cloned and are found in several brain regions 
including the hippocampus of the nuclei, dendritic spines, and axon terminals of 
pyramidal neurons and interneurons (Milner et al., 2001; Milner et al., 2005). When 
estrogens bind to ERα or ERβ in the cytoplasm, they are dimerized and move into the 
nucleus where they bind to estrogen response elements (ERE) to initiate gene 
transcription (Cheskis et al., 2007). This so-called classic nuclear action of estrogens 
is considered somewhat slow because the cellular effects can take hours to be 
observed. However, ERα and ERβ can also activate hippocampal cell signaling 
cascades within minutes, suggesting an alternative mechanism of action. Such rapid 
effects have been termed “non-classical” mechanisms. One established non-classical 
mechanism regulating involves interactions between ERα and ERβ and metabotropic 
glutamate receptors (mGluR) to stimulate the phosphorylation of the transcription 
factor cAMP response element-binding protein (CREB) (Boulware et al., 2005). 
Although studies using ERα and ERβ knockout mice have suggested that the effects 
of E2 on hippocampal memory are dependent on ERβ, but not ERα (Liu et al., 2008; 
Walf et al., 2008), potential compensatory mechanisms after gene knockout 
throughout early development make it difficult to pinpoint the roles of each 
intracellular ER. Therefore, ERα-selective and ERβ-selective agonists have been 
developed to differentiate the role of each ER to memory formation.  
 Recently, our laboratory used ER agonists to show that the intracellular 
estrogen receptors ERα and ERβ can mediate the E2-induced enhancement of object 
recognition and object placement memory consolidation (Boulware et al., 2013). 
Specifically, bilateral infusion of propyl pyrazole triol (PPT, ERα agonist) or 
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diarylpropionitrile (DPN, ERβ agonist) into the DH immediately after OR or OP 
testing enhanced object recognition and object placement memory consolidation. Like 
E2, both PPT and DPN increased phosphorylation of the p42, but not the p44, isoform 
of ERK 5 minutes after infusion, and this activation was necessary for PPT and DPN 
to enhance memory. Because ERα and ERβ are not integral membrane proteins, it is 
unlikely that they activate ERK on their own. Instead, we found that both receptors 
must interact mGluR1 to rapidly activate ERK signaling and enhance memory 
consolidation (Boulware et al., 2013). 
 As an alternative to intracellular receptors, E2 may regulate memory by 
binding to membrane ERs (mERs). The existence of specific mERs has been the 
subject of intensive debate in recent years because they have yet to be cloned. 
Candidate mERs include G-protein coupled estrogen receptor 1 (GPER), ER-X, and 
Gq-mER. Despite the uncertainty surrounding the identity of the mERs, these 
receptors can be examined generally using bovine serum albumin (BSA)-conjugated 
E2 (BSA-E2), which is membrane impermeable (Taguchi et al., 2004). Unlike E2, 
BSA-E2 does not activate estrogen responsive gene transcription (Watters et al., 1997). 
Instead, BSA-E2 rapidly activates calcium signaling and ERK phosphorylation in vitro 
and in vivo (Carrer et al., 2003; Wu et al., 2011). In addition, our laboratory has found 
that infusion of BSA-E2 into the DH of ovariectomized female mice enhances OR 
memory consolidation in an ERK-dependent manner (Fernandez et al., 2008). These 
effects were not blocked by an intracellular ER antagonist (ICI 182,780) (Fernandez 
et al., 2008), suggesting that mER activation can influence memory and ERK 
activation independently of intracellular ERs. Although informative, studies using 
BSA-E2 do not provide information about which mERs are involved. Given the 
difficulty of identifying these ERs, it is therefore, challenging to target them 
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pharmacologically or genetically. However, the availability of agonist and antagonist 
drugs for the recently named GPER had led to an increasing number of studies aimed 
at understanding the role of this putative mER in memory formation.  
 
G-Protein Coupled Estrogen Receptor 1 (GPER) 
 GPER is a G-protein coupled receptor, previously known as the orphan 
GPCR called GPR30 (Funakoshi et al., 2006). Although has been considerable debate 
about whether GPER is, indeed, a mER (Langer et al., 2010), there was sufficient 
evidence from peripheral tissues that the receptor’s name was officially changed from 
GPR30 to GPER. GPER is expressed at high levels in the brain, including the 
hippocampus (Brailoiu et al., 2007). Within the hippocampus, GPER is localized 
within dendritic spines of excitatory synapses and peri-synaptic regions in CA1 
hippocampal neurons (Akama et al., 2013; Srivastava and Evans, 2013). GPER is a 
seven transmembrane domain (7TMD) receptor that includes the heterotrimeric G 
protein subunits Gαβγ (Filardo and Thomas, 2005). The Gα protein is involved in 
regulating ion channels and membrane-associated enzymes, whereas the Gβγ-subunit 
plays a role in activating protein kinase cascades (Luttrell et al., 1999; Filardo and 
Thomas, 2005). Importantly, G proteins provide signaling mechanisms critical for the 
regulation of different mitogen-activated protein kinase (MAPK)  (Goldsmith and 
Dhanasekaran, 2007). Some studies suggest that activation of the SRC-like tyrosine 
kinase downstream of GPER can promote the induction of the MAPK pathway 
(Maggiolini and Picard, 2010), and that both E2 and the GPER agonist G-1 increase 
ERK phosphorylation in pancreatic beta cells (Sharma and Prossnitz, 2011). However, 
other studies indicate that activation of GPER does not induce ERK phosphorylation 
in human vascular smooth muscle cells (Ortmann et al., 2011) and that ERK 
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inhibition has no effect on the ability of G-1 to induce DNA synthesis in human 
epithelial cells (Holm et al., 2011). Several other downstream targets of GPER have 
been characterized, including a SRC-like tyrosine kinase (Quinn et al., 2009), PKA 
via cAMP (Thomas et al., 2005), PI3K/Akt (Maggiolini and Picard, 2010), and the 
Notch signaling pathway (Ruiz-Palmero et al., 2011).  
 Interestingly, some reports have demonstrated that ERα localized at the 
membrane interacts directly with various G-proteins (Wyckoff et al., 2001; Kumar et 
al., 2007). However, potential interaction between GPER and intracellular ERs has 
not been examined. As mentioned above, whether GPER is, in fact, an estrogen 
receptor has been a matter of heated debate. Some investigators insist that GPER is 
not a true ER, but potentially has a collaborative role in mediating the biological 
actions of estrogens (Levin, 2009). Although this issue has not yet been resolved for 
neural tissue, evidence in peripheral tissues suggests that GPER binds E2 with a high 
affinity (Thomas et al., 2005), prompting the name change from GPR30 to GPER.  
 The contribution of GPER to hippocampal memory formation is not well 
established. However, some pharmacological studies have examined the role of GPER 
in memory processes using systemic injections of the GPER agonist, G-1, and 
antagonist, G-15. G-1 is a selective agonist for GPER that does not bind ERα and 
ERβ at concentrations up to 10 µM in vitro (Bologa et al., 2006; Blasko et al., 2009) 
and G-15 is selective antagonist for GPER that also does not bind to ERα and ERβ at 
concentrations up to 10 µM in vitro using COS7 cells (fibroblast-like cells) (Dennis et 
al., 2009). One recent study showed that chronic systemic treatment with G-1 mimics 
the beneficial effects of E2 on spatial working memory in young female rats 
(Hammond et al., 2009). In contrast to G-1, systemic treatment with G-15 impairs 
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spatial working memory in young female rats (Hammond and Gibbs, 2011). Although 
these studies suggest that GPER regulates hippocampal memory, their use of systemic 
injections do not permit definitive conclusions about the role of hippocampal GPER 
in memory formation. To address this issue, this thesis employed direct DH infusions 
of G-1 and G-15 to pinpoint the role of hippocampal GPER in memory consolidation. 
 
c-Jun N-terminal kinase (JNK) 
 G-proteins like GPER can activate numerous cell-signaling cascades.  As 
will be discussed below, our results led us to examine cascades other than ERK, 
including the JNK signaling pathway. Like ERK, JNK belongs to the mitogen-
activated protein kinase (MAPK) family and has a kinase signaling cascade structure 
in which mitogen-activated protein kinase kinase (MKK) 4 and MKK7 are direct 
activators of JNK (Haeusgen et al., 2009). JNK has more than 60 substrates, including 
a variety of nuclear transcription factors such as c-Jun, ATF2, and Elk-1, as well as 
cytoplasmic substrates such as cytoskeletal proteins and mitochondrial proteins like 
Bcl-2 and Bcl-xl (Antoniou and Borsello, 2012).  
 JNK has most often been studied in the context of cellular stress and 
apoptosis related to heat shock or DNA damage (Kyriakis and Avruch, 2001; 
Reinecke et al., 2013). In the nervous system, JNK plays an important role in synaptic 
plasticity, neuronal regeneration, and brain development (Tararuk et al., 2006; 
Waetzig et al., 2006). Evidence has also suggested that JNK activity is involved in the 
regulation of the post-synaptic density protein called post-synaptic density-95 (PSD-
95) (Kim et al., 2007). Interactions between GPER and PSD-95 have been identified 
in hippocampal dendritic spines (Akama et al., 2013), suggesting a possible link 
between JNK and GPER at the synaptic membrane. Much less is known, however, 
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about JNK’s role in learning and memory. Studies of JNK inhibitor-treated mice 
suggest a facilitative role of JNK activation in long-term inhibitory avoidance 
memory and neuroprotective effects in hippocampal neurons (Bevilaqua et al., 2007; 
Carboni et al., 2008). In addition, a study using JNK1-deficient (JNK1-/-) mice found 
that JNK1 may play a crucial role in short-term synaptic plasticity and mGluR-
dependent long-term depression (Li et al., 2007). However, other data indicate that 
JNK inhibition in the hippocampus enhances short-term memory (Bevilaqua et al., 
2003), suggesting that JNK may also negatively regulate memory. Therefore, the role 
of JNK signaling in hippocampal memory formation is unclear. Furthermore, nothing 
is known about whether JNK signaling is involved estrogenic regulation of the 
hippocampus or memory. As such, the role of JNK in mediating the effects of E2 or 
GPER on memory was of interest in this thesis. 
 
Aims 
Given the uncertainty surrounding the role of the putative mER GPER in memory 
formation, the primary goals of this thesis were to pinpoint the role of GPER in 
regulating hippocampal object recognition and spatial memory consolidation and 
determine the molecular mechanisms underlying this regulation. To achieve these 
goals, we conducted a series of studies in which we infused a GPER agonist or 
antagonist directly into the DH of ovariectomized mice immediately after training in 
the OR and OP tasks.. We found that GPER regulates both object recognition and 
spatial memory consolidation, but that these effects were dependent on JNK, but not 
ERK activation in the DH. Next, we found that the memory-enhancing effects of E2 
were not dependent on JNK or GPER activation in the DH. Collectively, these data 
suggest that GPER enhances hippocampal memory consolidation by activating 
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different cell signaling cascades than E2. As such, GPER does not appear to function 
as a mER in the hippocampus. 
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Materials and Methods 
Subjects 
 Subjects were female C57BL/6 mice (8-10 weeks of age) purchased from 
Taconic Biosciences (Cambridge City, IN). After surgery, mice were singly housed in 
a room with a 12-hour light/dark cycle, and were allowed ad libitum access to food 
and water. All behavioral testing was performed between 9 am and 6 pm in a quiet 
room with dim lights. All procedures were approved by the University of Wisconsin-
Milwaukee Institutional Animal Care and Use Committee, and followed policies set 
forth by the National Institutes of Health Guide for the Care and Use of Laboratory 
Animals. 
 
Surgery  
 At least one week prior to behavioral testing, mice were bilaterally 
ovariectomized and implanted with chronic indwelling guide cannuale within the 
same surgical session as previously described (Boulware et al., 2013; Fortress et al., 
2013b; Fortress et al., 2014). Mice were anesthetized with isoflurane gas (2% 
isoflurane in 100% oxygen) and secured in a stereotaxic apparatus (Kopf Instruments). 
Following ovariectomy, mice were implanted with guide cannulae (22 gauge, C232G, 
Plastics One) into the DH (-1.7 mm AP, ±1.5 mm ML, -2.3 mm DV) or DH and 
dorsal third ventricle (intracerebroventricular (ICV); -0.9 mm AP, ±0.0 mm ML, -2.3 
mm DV) as previously performed (Boulware et al., 2013; Fortress et al., 2013b; 
Fortress et al., 2014). Dummy cannulae (C232DC, Plastics One) were inserted into all 
guide cannulae to preserve patency of the guide cannulae.  Cannulae were fixed to 
the skull with dental cement (Darby Dental Supply) that served to close the wound. 
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Mice were allowed 7 days to recover from surgery before the start of behavioral 
testing. 
 
Drugs and infusions 
 During infusions, mice were gently restrained and dummy cannulae were 
replaced with an infusion cannula (C3131; DH: 28 gauge, extending 0.8 mm beyond 
the 1.5 mm guide; ICV: 28 gauge, extending 1.0mm beyond the 1.8 mm guide) 
attached to PE20 polyethylene tubing that was mounted on a 10 µl Hamilton syringe. 
Infusions were controlled by a microinfusion pump (KDS Legato 180; KD Scientific). 
All infusions were conducted immediately post-training at a rate of 0.5 µl/minute in 
the DH or 1 µl/2 minutes into the dorsal third ventricle as described previously 
(Boulware et al., 2013; Fortress et al., 2013b; Fortress et al., 2014). Infusion cannulae 
remained in place for 1 min after each infusion to prevent diffusion back up the 
cannula track. For studies in which E2 or G-1 was administered in combination with 
G-15 or a cell-signaling inhibitor, the antagonist or cell-signaling inhibitor was first 
infused bilaterally into the DH and then E2 or G-1 was infused ICV immediately 
afterwards. We routinely use this triple infusion protocol to prevent possible tissue 
damage from two DH infusions in rapid succession (Fernandez et al., 2008; Fan et al., 
2010; Zhao et al., 2010; Zhao et al., 2012; Boulware et al., 2013; Fortress et al., 
2013b). This protocol allows us to infuse estrogenic compounds adjacent to the DH 
while inhibiting receptor or cell-signaling activation directly within the DH.   
 G-1, 1-[4-(6-bromobenzo[1,3]dioxol-5yl)-3a,4,5,9b-tetrahydro-3H-
cyclopenta [c]quinolin-8-yl]-ethanone (Azano biotech) was dissolved in 16% 
dimethylsulfoxide (DMSO) and infused at doses of 2 or 4 ng/hemisphere into the DH 
or 8 ng ICV. G-1 is a selective agonist for GPER that does not bind ERα and ERβ at 
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concentrations up to 10 µM in vitro (Bologa et al., 2006; Blasko et al., 2009). The 
vehicle control for G-1 was 16% DMSO in 0.9% saline. G-15, (3aS*,4R*,9bR*)-4-(6-
Bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta[c]quinoline (Azano biotech) 
was dissolved in 2% DMSO and infused at doses of 1.85, 3.7, and 7.4 ng/hemisphere 
into the DH. G-15 is selective antagonist for GPER that also does not bind to ERα 
and ERβ at concentrations up to 10 µM in vitro (Dennis et al., 2009). The vehicle 
control for G-15 was 2% DMSO in 0.9% saline.  
Cyclodextrin-encapsulated E2 (Sigma-Aldrich) was dissolved in 0.9% saline 
and infused at doses of 5 µg/hemisphere into the DH or 10 µg ICV (Zhao et al., 2012; 
Boulware et al., 2013). The vehicle control for E2 was 2-hydroxypropyl-β-
cyclodextrin (HBC, Sigma-Aldrich), dissolved in 0.9% saline using the same amount 
of cyclodextrin as E2 for infusions. The JNK inhibitor SP600125 (Anthra[1,9-
cd]pyrazol-6(2H)-one, Sigma-Aldrich) was dissolved in 2% DMSO and infused at 
doses of 0.11, 0.55, and 2.75 ng/hemisphere into the DH. SP600125 is a selective 
inhibitor for JNK that does not affect ERK and p38 at concentrations below 10 µM 
(Bennett et al., 2001). The vehicle control for SP600125 was 2% DMSO in 0.9% 
saline. The MEK inhibitor U0126 (1,4-diamino-2,3-dicyano-1,4-bis (o-
aminophenylmercapto) butadiene, Promega) was dissolved in 25% DMSO and 
infused at a dose of 0.5 µg/hemisphere into the DH. This dose does not impair OR and 
OP memory by itself (Fernandez et al., 2008; Boulware et al., 2013), and therefore, 
any effects of this drug in combination with E2 or G-1 cannot be attributed to a 
general memory impairing effect of this compound. The vehicle control for U0126 
was 25% DMSO in 0.9% saline. 
 
Object recognition and object placement 
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 OR and OP were conducted to examine hippocampus-dependent object 
recognition and spatial memory. Both tasks have been shown to involve dorsal 
hippocampal function (Baker and Kim, 2002; Luine et al., 2003; Frye et al., 2007; 
Cohen et al., 2013) and are sensitive to E2 treatment (Gresack and Frick, 2006; Zhao 
et al., 2010). Before the start of behavioral training, mice were handled (1 min/day) 
for three days to acclimate them to the experimenters. They were also familiarized 
with objects by placing a small Lego not used during testing in their home cage. At 
the start of training, mice were habituated to the empty white arena (width, 60 cm; 
length, 60 cm; height, 47 cm) by allowing them to explore for five min/day for two 
consecutive days. On third day, mice were habituated for two minutes in the arena, 
and then placed in a holding cage while two identical objects were placed near the 
northwest and northeast corners of the arena. Mice were then returned to the arena 
and allowed to freely explore the objects until they accumulated 30 s of investigation. 
Immediately after this training, mice were infused and then returned to their home 
cage. After 24 or 48 h, memory was tested by allowing mice to accumulate 30 s 
exploring a novel object and an object identical to the familiar training objects. Time 
spent with the objects was recorded using by ANYmaze tracking software (Stoelting). 
Because mice inherently prefer novelty, mice who remember the familiar object spend 
more time investigating the novel object than chance (15 s). Vehicle-infused mice do 
not remember the familiar object 48 h after training (Gresack et al., 2007), so we used 
this delay to test the memory enhancing effects of E2 and G-1. However, vehicle-
infused females do remember the familiar object 24 h after training (Gresack et al., 
2007), so this shorter delay was used to test for potential memory impairing effects of 
G-15 and cell-signaling inhibitors.  
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The OP task used the same apparatus and general procedure as OR, but 
instead of substituting a novel object for a training object during testing, one familiar 
object was moved to the Southeast or Southwest corner of the testing arena. Because 
vehicle-infused females remember the original object placement after 4 h, but not 24 
h(Boulware et al., 2013), we used the 24-h delay to test memory enhancing effects of 
E2 and G-1 and the 4-h delay to test memory impairing effects of G-15 and cell-
signaling inhibitors. Two weeks separated OR and OP testing to allow acute effects of 
the drug infusions to dissipate prior to the next infusion (n = 6-12/group).  
 
Western blotting 
Western blotting was performed as described previously (Fernandez et al., 
2008; Boulware et al., 2013). To determine the effects of G-1 on DH cell signaling, 
mice were cervically dislocated and decapitated, and the dorsal hippocampus was 
dissected bilaterally 5, 15, or 30 min after infusion and stored at -80°C until 
homogenization. To determine the effects of E2, GPER compounds, and cell-signaling 
inhibitors on DH cell signaling, the DH was dissected bilaterally 5 min after infusion. 
DH tissues were resuspended 50 µl/mg in lysis buffer and homogenized by sonication 
(Branson Sonifier 250). Proteins were then electrophoresed on 10% Tris-HCl precast 
gels (Bio-Rad) and transferred to PVDF membranes (Bio-Rad). Western blots were 
blocked with 5% skim milk and incubated with primary antibodies (phospho-ERK, 
phospho-Akt, phospho-PI3K, phospho-JNK, and phospho-ATF2, 1:1000; Cell 
Signaling Technology) overnight. Blots were then incubated with the appropriate 
HRP-conjugated secondary antibody (1:5000; Cell Signaling), and developed using 
West Dura chemiluminescent substrate (Pierce). A ChemiDocMP gel imager (Bio-Rad) 
was used for signal detection of protein expression. Densitometry was performed 
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using Carestream Molecular Imaging Software (Carestream Healthcare). Blots then 
were stripped with 0.2M NaOH and incubated with antibodies (total-ERK, total-Akt, 
total-PI3K, and total-JNK, 1:1000; β-actin, 1:5000; Cell Signaling Technology) for 
protein normalization. Data were represented as immunoreactivity percent of vehicle 
controls. Treatment effects were measured within single gels (n = 5-8/group). 
 
Statistics 
For OR and OP data, one-sample t-tests were conducted using SPSS (IBM, 
Armonk, NY) to determine if each group spent more time than chance (15 s) 
exploring the novel or moved object (Gresack and Frick, 2003). Western blotting data 
were analyzed in GraphPad Prism 6 (La Jolla, CA) using one-way ANOVA followed 
by Fisher’s LSD posthoc tests and selected t-tests . Significance was determined at p 
< 0.05. 
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Results 
GPER regulates hippocampal memory consolidation 
 We first infused the GPER agonist G-1 into the DH to determine if activation 
of GPER in the DH enhances object recognition and object placement memory 
consolidation in a manner similar to E2. Mice received bilateral DH infusion of 
vehicle (16% DMSO) or on of two doses of G-1 (2 or 4 ng/hemisphere) immediately 
after OR training. Forty-eight hours later, mice infused with vehicle of 2 ng G-1 spent 
no more time with the novel object than chance (15 s). In contrast, mice infused with 
4 ng/hemisphere of G-1 spent more time exploring the novel object than chance (t(8) = 
2.56, p = 0.03; Fig.1A), suggesting that 4 ng G-1 enhanced object recognition 
memory consolidation. Two weeks after OR testing, mice were trained in OP and then 
were immediately infused with vehicle, 2 ng G-1, or 4 ng G-1. Twenty-four hours 
later, mice infused with vehicle or 2 ng G-1 did not exhibit a preference for the moved 
object. However, as in OR, mice receiving 4 ng/hemisphere of G-1 spent significantly 
more time than chance with the moved object (t(9) = 3.81, p = 0.004; Fig. 1B), 
demonstrating enhanced spatial memory consolidation.  
 Because these data suggest that activation of GPER facilitates hippocampal 
memory consolidation, we next examined effects of GPER antagonism on memory 
consolidation. Immediately after OR or OP training, mice received bilateral DH 
infusion of vehicle (2% DMSO) or one of three doses of G-15 (1.85, 3.7, or 7.4 
ng/hemisphere). Mice receiving vehicle (t(8) = 3.52, p = 0.008) or 1.85 ng/hemisphere 
of G-15 (t(7) = 3.32, p = 0.013) showed preference for the novel object 24 h after OR 
training suggesting intact object recognition memory after treatment with a low dose 
of G-15. In contrast, mice receiving 3.7 (t(8) = 2.02, p = 0.08) or 7.4 (t(6) = 0.89, p = 
0.41) ng/hemisphere of G-15 did not (Fig. 1C), suggesting that these doses impaired 
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Figure 1. GPER activation enhances OR and OP memory consolidation. A, Mice receiving DH 
infusion of 4 ng/hemisphere G-1 (but not vehicle or 2 ng G-1) spent more time than chance 
(dashed line at 15 s) with the novel object 48 hr after training, indicating enhanced memory for 
the familiar object (n = 6-9/group). B, Similarly, mice infused with 4 ng G-1, but not vehicle or 2 
ng G-1, spent significantly more time with the moved object than chance 24 h after OP training, 
indicating enhanced spatial memory (n = 9-10/group). C, Mice receiving 3.7 or 7.4 
ng/hemisphere G-15 exhibited impaired OR memory consolidation 24 h after DH infusion, 
whereas mice receiving vehicle or 1.85 ng G-15 did not (n = 7-9/group). D, In OP, 7.4 ng G-15 
impaired spatial memory consolidation 4 h after DH infusion, but no other dose of G-15 affected 
memory (n = 6-9/group).  E, F, ICV infusion of 4 ng/hemisphere G-1 significantly enhanced 
OR (E) and OP (F) memory tested 48 h and 24 h after infusion, respectively (n = 8-11/group).. 
However, DH infusion of 1.85 ng/hemisphere G-15 abolished these effects, suggesting that 
activation of GPER is necessary for G-1-mediated hippocampal memory enhancement. Each bar 
represents the mean ± SEM time spent with the novel or moved object (*p < 0.05, **p < 0.01 
relative to chance)..  
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object recognition memory consolidation. In OP, mice receiving DH infusion of 
vehicle (t(8) = 2.62, p = 0.03), 1.85 ng G-15 (t(7) = 3.32, p = 0.013), or 3.7 ng G-15 (t(8) 
= 2.02, p = 0.08) spent significantly more time than chance (15 s) with the moved 
object, whereas mice infused with 7.4 ng G-15 did not (Fig. 1D). That only the high 
dose of G-15 impaired spatial memory consolidation suggests that spatial memory 
may be less sensitive to the effects of G-15 antagonism. that 1.85 ng/hemisphere of G-
15 did not impair memory consolidation on its own and GPER inhibition impairs 
hippocampal memory although the sensitivity of task is a little bit different.  
 Finally, to confirm that G-15 acts as a GPER antagonist, we examined 
whether G-15 could block the memory-enhancing effects of G-1. To this end, we 
infused 8 ng G-1 into the dorsal third ventricle because bilateral infusion of 4 
ng/hemisphere G-1 enhanced memory in both tasks. We also infused 1.85 ng/ 
hemisphere G-15 into the DH because this dose had no detrimental effects on memory 
in both tasks. Immediately after training in each task, mice received a DH infusion of 
vehicle (2% DMSO) or G-15 (1.85 ng/hemisphere) followed immediately by an ICV 
infusion of vehicle (16% DMSO) or G-1 (8 ng). OR and OP retention were tested 48 
and 24 hours later, respectively. In both tasks, G-15 blocked the memory enhancing 
effects of G-1 (Fig. 1E,F). Only mice receiving G-1 + vehicle showed a significant 
preference for the novel object (t(7) = 2.68, p = 0.032; Fig 1E) and moved object (t(8) = 
2.46, p = 0.04; Fig 1F). These results demonstrate that GPER activation is necessary 
for G-1 to enhance hippocampal memory consolidation in female mice, and suggest 
that GPER regulates both object recognition and spatial memory consolidation. 
 
G-1 does not activate ERK or PI3K/Akt signaling in the DH 
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 We have previously shown that the enhanced memory consolidation 
induced by DH infusion of E2 or agonists of ERα and ERβ is dependent on DH p42 
ERK phosphorylation (Fernandez et al., 2008; Boulware et al., 2013). To determine 
whether GPER also enhances memory by activating p42 ERK, we first measured the 
effects of GPER activation on ERK phosphorylation. Mice received bilateral DH 
infusion of 4 ng G-1 and the DH was dissected bilaterally 5, 15, or 30 min later. 
 
 
 
Figure 2. GPER does not activate the ERK or PI3K/Akt signaling pathways. A, G-1 (4 
ng/hemisphere) infusion did not increase DH p42 and p44 ERK phosphorylation relative to 
vehicle 5, 15, or 30 min after DH infusion. B, G-1 infusion significantly reduced Akt 
phosphorylation levels in the DH 30 min after infusion. C, G-1 infusion did not alter PI3K 
phosphorylation relative to vehicle 5, 15, or 30 min after DH infusion. Each bar represents the 
mean ± SEM percent change from vehicle controls (*p < 0.05 relative to vehicle). Insets are 
representative Western blots. (n = 5/group). 
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In contrast to E2(Fernandez et al., 2008; Boulware et al., 2013), G-1 infusion did not 
significantly increase levels of phospho-p42 ERK at any time point examined (F(3,16) 
= 0.72; Fig. 2A). G-1 also did not affect levels of phospho-p44 ERK (F(3,16) = 3.07; 
Fig. 2A). We then examined activation of the PI3K/Akt signaling pathway because we 
have previously demonstrated that activation of this signaling pathway is necessary 
for E2 to activate ERK and enhance OR memory consolidation in young and middle-
aged female mice (Fan et al., 2010; Fortress et al., 2013b). However, G-1 did not 
significantly increase levels of phospho-Akt (F(3,16) = 3.94, p > 0.05; Fig. 2B) or 
phospho-PI3K (F(3,16) = 0.68; p > 0.05; Fig. 2C). In fact, G-1 decreased levels of 
phospho-Akt 30 min after infusion (Fig. 2B). Collectively, these data show that GPER 
activation does not activate ERK or PI3K/Akt signaling in the DH and suggest that 
the effects of GPER activation on DH cell signaling are different from those of E2 or 
ER agonists.  
 
GPER activation leads to rapid JNK phosphorylation in the DH  
 We next investigated whether GPER activation could phosphorylate c-Jun 
N-terminal Kinase (JNK) in the DH. As a seven transmembrane domain receptor, 
GPER is comprised of heterotrimeric G protein subunits Gαβγ (Filardo and Thomas, 
2005), and the Gβγ-subunit plays a role in activating protein kinase cascades such as 
ERK and JNK (Luttrell et al., 1999; Filardo and Thomas, 2005; Goldsmith and 
Dhanasekaran, 2007). Moreover, JNK is known to play an important role in synaptic 
plasticity, neuronal regeneration, and brain development (Tararuk et al., 2006; 
Waetzig et al., 2006). Therefore, we thought it possible that GPER might activate one 
or both of the two JNK isoforms (p46 and p54). Mice bilaterally infused into the DH 
with vehicle or 4 ng G-1 exhibited a significant increase in the phosphorylation of 
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both the p46 (F(3,16) = 13.46, p < 0.001; Fig. 3A) and p54 (F(3,16) = 6.335, p < 0.01; Fig. 
3B) isoforms of JNK 5 min after infusion. These effects were transient, as levels of 
both phosphorylated isoforms returned to baseline by 15 min after infusion. We next 
examined phosphorylation of the downstream JNK transcription factor called 
activating transcription factor 2 (ATF2) (Antoniou and Borsello, 2012). As with JNK, 
G-1 infusion significantly increased levels of, phospho-ATF2 5 min after DH infusion 
 
 
 
Figure 3. GPER activation increases JNK phosphorylation in the DH. A,B, DH infusion of G-1 (4 
ng/hemisphere) significantly increased phosphorylation of the JNK p46 isoform (A) and p54 
isoform (B) within 5 min. Levels returned to baseline 15 min later. C, Similarly, G-1 infusion 
significantly increased phosphorylation of the downstream JNK transcription factor ATF2 in the 
DH 5 min after infusion. (n = 5/group). 
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(F(3,16) = 3.03, p < 0.05; Fig. 3C), and levels returned to baseline by 15 min after 
infusion.  
To confirm that the G-1 mediated-JNK activation observed occurred via 
GPER activation, we next examined if G-15 could block the effects of G-1 on JNK 
 
 
 
 
Figure 4. GPER antagonist blocks the G-1-mediated JNK phosphorylation in DH. A,B, ICV 
infusion of 8 ng G-1 significantly increased levels of phosphorylated p46 JNK (A) and p54 JNK (B) 
5 min after infusion. However, these effects were abolished by DH infusion of G-15 indicating that 
GPER activation is necessary for G-1 to activate JNK signaling. C, Neither G-1 nor G-15 altered 
ERK phosphorylation. Each bar represents the mean ± SEM percent change from vehicle (*p < 
0.05, **p < 0.01, ***p < 0.001). Insets are representative Western blots. (n = 6/group). 
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activation. Mice received DH infusion of vehicle or G-15, and ICV infusion of 
vehicle or G-1. Consistent with the effects of DH G-1 infusion, ICV infusion of G-1 
increased phosphorylation of both the p46 (F(2,15) = 4.97, p < 0.05; Fig 4A) and p54 
(F(2,15) = 7.89, p < 0.01; Fig 4B) isoforms of JNK 5 min after infusion. Infusion of G-
15 into the DH completely blocked these effects (Fig. 4A,B), suggesting that GPER 
activation induces JNK phosphorylation in the DH. In contrast, ICV and DH infusion 
of G-1 and G-15 did not significantly alter ERK phosphorylation (Fig. 4C). 
 
Activation of JNK is necessary for GPER to influence hippocampal memory 
consolidation 
Given the rapid activation of JNK by G-1, we next examined whether this 
activation is necessary for G-1 to enhance memory consolidation. To do so, we used 
the JNK activation inhibitor SP600125. We first needed to find a dose of SP600125 
that did not block memory consolidation on its own. Therefore, we infused mice with 
vehicle (2% DMSO) or one of two doses of SP600125 (0.55 or 2.75 ng/hemisphere) 
immediately after OR or OP training. Mice receiving vehicle (t(6) = 3.27, p = 0.02) or 
either dose of SP600125 (0.55 ng, t(5) = 2.7, p = 0.043; 2.75 ng, t(7) = 3.46, p = 0.01) 
spent significantly more time than chance with the novel object 24 h after OR training 
(Fig. 5A), suggesting that neither dose of SP600125 impaired OR memory 
consolidation. Similarly, mice infused with vehicle (t(8) = 3.87, p = 0.005) or either 
dose of SP600125 (0.55 ng, t(9) = 3.45, p = 0.007; 2.75 ng, t(7) = 3.7, p = 0.008) spent 
significantly more time than chance with the moved object 4 h after OP training (Fig. 
5B), indicating neither dose impaired OP memory consolidation. Because neither dose 
affected memory on its own, we selected the highest behaviorally ineffective dose of 
SP600125 (2.75 ng/hemisphere) for our remaining studies. 
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To test whether activation of JNK or ERK was necessary for G-1 to enhance 
memory consolidation, we next infused mice with G-1 plus 2.75 ng SP600125 or the 
ERK activation inhibitor U0126 at a dose (0.5 µg/hemisphere) that has no effect on 
OR or OP on its own (Fernandez et al., 2008; Boulware et al., 2013). A new set of 
mice received DH infusion of vehicle (25% DMSO), 2.75 ng SP600125, or 0.5 µg 
U0126 and ICV infusion of vehicle (16% DMSO) or 8 ng G-1 immediately after OR 
     
  
 
Figure 5. JNK inhibition blocks the GPER-mediated memory enhancement in DH. A, Mice 
receiving DH infusion of vehicle or the JNK inhibitor SP600125 (0.55 or 2.75 ng/hemisphere) spent 
significantly more time than chance with the novel object 24 hr after training, suggesting that 
neither dose of SP600125 impaired memory on its own (n = 6-8/group). B, Similarly, neither dose 
of SP600125 impaired OP memory tested 4 h after DH infusion (n = 6-10/group).  C, D, 
Immediately after OR or OP training, mice received DH infusion of vehicle, SP600125 (1.85 
ng/hemisphere), or U0126 (0.5 µg/hemisphere) followed by ICV infusion of vehicle or G-1 (8 ng). 
ICV infusion of G-1 significantly enhanced OR memory (C) and OP memory (D). SP600125 
blocked these effects (C, D), but U0126 did not, suggesting that activation of JNK, but not ERK, is 
necessary for GPER-mediated hippocampal memory enhancement (n = 7-10/group).. Each bar 
represents the mean ± SEM time spent with the novel or moved object (*p < 0.05, **p < 0.01 , ***p 
< 0.001 relative to chance).   
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and OP training. Memory in OR and OP was tested 48 and 24 hours later, respectively. 
In both tasks, SP600125, but not U0126, blocked the memory-enhancing effects of G-
1 (Fig. 5C,D). Mice receiving G-1 + vehicle showed a significant preference for the 
novel object (t(9) = 2.48, p = 0.04) and moved object (t(6) = 6.37, p = 0.0007), whereas 
mice receiving G-1 + SP600125 did not (novel object, t(8) = 1.16, p = 0.28; moved 
 
 
 
Figure 6. JNK inhibition blocks the GPER-mediated cell signaling in DH. A, B, ICV infusion of 8 
ng G-1 increased phosphorylation of p46 JNK (A) and p54 JNK (B) 5 min later. These effects were 
blocked by DH SP600125 infusion. C, Neither G-1 nor SP600125 altered ERK phosphorylation (n 
= 7-8/group). 
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object, t(7) = 0.86, p = 0.42), suggesting that JNK activation is necessary for G-1 to 
enhance memory consolidation. In contrast, mice infused with G-1 + U0126 spent 
significantly more time than chance with the novel object (t(8) = 2.83, p = 0.02) and 
moved object (t(10) = 2.48, p = 0.03), suggesting that ERK activation is not necessary 
 
 
 
Figure 7. ERK inhibition does not alter the GPER-mediated cell signaling in DH. A, B, The increase 
in p46 (A) and p54 (B) phosphorylation induced by ICV infusion of 8 ng G-1 was not blocked by 
DH U0126 infusion. C, Neither G-1 nor the behaviorally subeffective dose of U0126 altered ERK 
phosphorylation. Each bar represents the mean ± SEM percent change from vehicle (*p < 0.05, **p 
< 0.01). Insets are representative Western blots (n = 7-8/group). 
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for G-1 to enhance memory consolidation. We next examined the effects of JNK and 
ERK inhibition on G-1 mediated hippocampal cell signaling. Consistent with the 
behavioral data, ICV infusion of G-1 increased phosphorylation of both p46 JNK 
(F(2,19) = 6.56, p < 0.01; Fig. 6A) and p54 JNK (F(2,19) = 6.47, p < 0.01; Fig. 6B) 5 min 
after infusion. DH infusion of SP600125 abolished the effects of G-1 on p46 and p54 
JNK (Fig. 6A,B). In contrast, G-1 and SP600125 did not significantly alter ERK 
phosphorylation (Fig. 6C). Unlike SP600125, U0126 did not block the GPER-
mediated JNK activation (Fig. 7A,B). Whereas G-1 increased phosphorylation of both 
p46 JNK (F(2,15) = 4.44, p < 0.05; Fig. 7A) and p54 JNK (F(2,15) = 6.68, p < 0.01; Fig. 
7B) 5 min after infusion, U0126 did not block the effects of G-1 on p46 JNK (t(10) = 
2.35, p < 0.05; Fig. 4H) and p54 JNK (t(10) = 2.34, p < 0.05; Fig. 7B). Moreover, 
neither G-1 nor U0126 infusion altered ERK activation (Fig. 7C). These data suggest 
that ERK activation does not regulate G-1-induced hippocampal JNK activation. 
Together, these results support that activation of JNK, but not ERK, is essential for 
GPER to induce memory enhancement.  
 
E2-mediated hippocampal memory consolidation is independent of GPER and 
JNK activation 
 We have previously demonstrated that E2 enhances hippocampal memory 
consolidation by ERα− or ERβ-mediated ERK activation in the DH (Fernandez et al., 
2008; Boulware et al., 2013). In contrast, above data support that the G-1-induced 
enhancement of hippocampal memory consolidation is dependent on hippocampal 
JNK activation, rather than ERK activation. This finding begs the question of whether 
E2-induced memory enhancements are also dependent on JNK and/or GPER 
activation. To address this issue, we first examined the effects of E2 on JNK cell 
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signaling in the DH. Mice received bilateral DH infusion of the vehicle or E2 (5 µg/ 
hemisphere), and the DH was dissected bilaterally 5 or 10 min later. DH E2 infusion 
did not alter DH p46 JNK, and p54 JNK phosphorylation at either the 5 or 10 min 
time point (Fig. 8A,B), suggesting that E2 does not activate JNK in the DH. As our 
previous studies (Fernandez et al., 2008; Boulware et al., 2013), DH E2 infusion 
 
 
 
Figure 8. E2 increases activation of ERK, but not JNK, in the DH. A, B, DH infusion of E2 (5 
µg/hemisphere) did not alter levels of phospho-p46 JNK (A) or phospho-p54 JNK (B) 5 or 10 min 
later. C, DH infusion of E2 (5 µg/hemisphere) significantly increased phosphorylation of p42 
ERK, but not p44 ERK, 5 min after infusion. Levels returned to baseline 10 min later. Each bar 
represents the mean ± SEM percent change from vehicle controls (*p < 0.05). Insets are 
representative Western blots. (n = 6/group). 
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increased phospho-p42-ERK 5 min after infusion (F(2,15) = 3.38, p < 0.05; Fig. 8C) but 
had no effect on p44 ERK (Fig. 8C). These data suggest that E2 increases activation of 
ERK, but not JNK, in the DH.   
Next, we investigated the effects of GPER and JNK inhibition on E2-
mediated hippocampal cell signaling. Mice received ICV and DH infusions, 
respectively, of vehicle + vehicle, E2 + vehicle, E2 + SP600125, or E2 + G-15, and DH 
tissue was collected 5 min later. As in our previous work (Boulware et al., 2013), ICV 
infusion of E2 increased levels of phospho-p42 ERK (F(3,20) = 7.6, p < 0.01), but not 
phospho-p44 ERK (F(3,20) = 0.7, p > 0.05) (Fig. 9A). The increase in p42 ERK was 
not blocked by DH infusion of G-15 and SP600125 (G-15, F(3,20) = 7.6, p < 0.001; 
SP600125, F(3,20) = 7.6, p < 0.05; Fig. 9A). As with DH infusion, ICV infusion of E2 
did not alter phosphorylation of p46 JNK or p54 JNK, whether alone or in 
combination with DH infusion of G-15 and SP600125 (Fig. 9B,C). Together, these 
data reiterate that E2 does not rapidly activate JNK in the DH and indicate that 
activation of JNK or GPER is not necessary for E2 to activate ERK in the DH.  
Given this finding, the next logical step was to determine whether JNK and 
GPER activation play a role in E2-mediated hippocampal memory enhancement. To 
do so, we infused mice with vehicle, G-15 (1.85 ng/hemisphere) or SP600125 (2.75 
ng/hemisphere) into the DH and vehicle or E2 (10 µg) into the dorsal third ventricle 
immediately after OR and OP training. OR and OP retention were tested 48 and 24 
hours later, respectively. In both tasks, mice receiving E2 + vehicle showed a 
significant preference for the novel object (t(5) = 2.73, p = 0.04; Fig 9D) and moved 
object (t(7) = 2.69, p = 0.03; Fig 9E), in agreement with our previous work (Boulware 
et al., 2013). Consistent with the lack of JNK activation observed above, SP600125 
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Figure 9. GPER and JNK inhibition do not affect the E2-mediated memory enhancement and cell 
signaling in the DH. A, ICV infusion of E2 (10 µg) increased phospho-p42 ERK levels 5 min after 
infusion; this effect was not blocked by DH infusion of G-15 or SP600125. ICV infusion of E2 (10 
µg) did not alter p44 ERK phosphorylation (n = 6/group). B, C, ICV infusion of E2 did not alfter 
p46 JNK (B) or p54 JNK (C) phosphorylation 5 min after infusion when infused with vehicle, G-
15, or SP600125 phosphorylation (n = 6/group). Each bar represents the mean ± SEM percent 
change from vehicle (*p < 0.05, **p < 0.01, ***p < 0.001). Insets are representative Western 
blots. D, E, Immediately after OR or OP training, mice received DH infusion of vehicle, G-15 
(1.85 ng/hemisphere), or SP600125 (2.75 ng/hemisphere) followed by ICV infusion of vehicle or 
E2 (10 µg). ICV infusion of E2 significantly enhanced OR memory (D) and OP memory (E), and 
these effects were not blocked by G-15 or SP600125 (D, E), suggesting that neither GPER nor 
JNK activation is necessary for E2 to enhance hippocampal memory consolidation (n = 6-
12/group). Each bar represents the mean ± SEM time spent with the novel or moved object (*p < 
0.05 relative to chance).  
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did not prevent E2 from enhancing OR or OP memory consolidation (Fig. 9D,E), as 
mice receiving E2 + SP600125 spent significantly more time with the novel object 
(t(11) = 2.36, p = 0.04) and moved object (t(9) = 2.45, p = 0.04). Interestingly, G-15 also 
did not block E2-induced memory enhancements in either task (Fig. 9D,E), as 
demonstrated by the fact that mice receiving E2 + G-15 spent significantly more time 
with the novel object (t(5) = 3.67, p = 0.01) and moved object (t(6) = 3.36, p = 0.02). 
These results suggest that neither JNK nor GPER activation in the DH is necessary for 
E2 to enhance hippocampal memory consolidation.  
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Discussion 
 The present study provides the first evidence that GPER, a putative estrogen 
receptor, regulates hippocampal memory consolidation in young ovariectomized 
female mice in an E2-independent manner. This conclusion is supported by several 
novel findings. First, GPER activation in the DH enhances OR and OP memory 
consolidation and increases JNK, but not ERK, phosphorylation in the DH. Second, 
the memory-enhancing effects of GPER activation are blocked by inhibition of JNK, 
but not ERK, in the DH. Finally, E2 infusion increases ERK, but not JNK 
phosphorylation in the DH, and the memory-enhancing effects of E2 are blocked by 
inhibition of ERK, but not JNK or GPER activation. Collectively, these data indicate 
that E2 enhances hippocampal memory consolidation in females by activating ERK, 
whereas GPER enhances hippocampal memory consolidation by activating JNK. As 
such, the data suggest that GPER in the DH does not function as an estrogen receptor 
to facilitate memory consolidation.  
Our findings showing that G-1 enhanced OR and OP memory consolidation 
are consistent with previous studies demonstrating that systemic injections of G-1 
enhanced spatial learning and memory in ovariectomized rats (Hammond et al., 2009; 
Hammond and Gibbs, 2011; Hawley et al., 2014). However, the rat data do not permit 
definitive conclusions about the role of hippocampal GPER in memory because 
systemic treatments do not specifically affect the hippocampus. Therefore, we used 
dorsal hippocampal infusions of G-1 to pinpoint the role of hippocampal GPER in 
regulating memory consolidation. To ensure that the effects of G-1 were specific to 
GPER, we tested whether G-15 could antagonize the effects of G-1, as some studies 
have indicated that G-1 can act in a GPER-independent manner. For example, in 
breast cancer cell lines, G-1 has been found to interact with an ER-α variant, ER- α 
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36, but not with GPER (Kang et al., 2010). Additionally, G-1 suppressed the 
proliferation of ovarian and breast cancer cells, whereas GPER siRNA or G15 did not 
attenuate the effects of G-1, suggesting that G-1 can act in a GPER-independent 
manner in cancer cell lines (Wang et al., 2012). In contrast to these proliferative cells, 
we found that G-15 infusion into the DH prevented G-1 from enhancing OR and OP 
memory consolidation, as well as increasing JNK phosphorylation. These data suggest 
that the effects of G-1 on memory and JNK activation are mediated by GPER in the 
hippocampus. Interestingly, although higher doses of G-15 on their own impaired 
both OR and OP memory consolidation, OP appeared to be a bit more sensitive to G-
15 than OR at the doses tested. Nevertheless, our finding that post-training DH 
infusion of G-15 dose-dependently impaired memory consolidation is consistent with 
previous data showing that chronic systemic treatment with G-15 dose-dependently 
impaired spatial working memory in ovariectomized rats (Hammond et al., 2012). 
Together, these data suggest an important role of GPER in hippocampal memory 
processes.  
 
The role of ERK in GPER-mediated memory enhancement  
 The molecular mechanisms through which GPER influences hippocampal 
memory have not been investigated previously. Therefore, one of the primary goals of 
this thesis was to pinpoint possible downstream effectors of GPER activation in the 
mouse hippocampus. Based on our previous findings showing that p42 ERK 
activation is necessary for E2 and agonists of ERα and ERβ to enhance OR and OP 
memory (Fernandez et al., 2008; Boulware et al., 2013), our initial hypothesis was 
that p42 ERK phosphorylation would also be necessary for G-1 to enhance memory. 
This hypothesis was also supported by other studies showing that activation of GPER 
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can activate the ERK pathway in pancreatic beta cells and the ERK activation effect is 
removed in GPER knockout mice model and in GPER depletion model by small 
interfering RNA (Maggiolini and Picard, 2010; Sharma and Prossnitz, 2011). We first 
showed that G-1 does not affect p42 or p44 ERK phosphorylation in the DH 5, 15, or 
30 min after infusion. These time points were selected based on our previous studies 
demonstrating that DH E2 infusion increases p42 ERK phosphorylation 5 min after 
DH infusion (Fernandez et al., 2008; Boulware et al., 2013; Fortress et al., 2013b). G-
1 has a slightly slower effects on the rapid mobilization of intracellular calcium (t1/2 ≈ 
30 s) than E2 (t1/2 ≈ 2 s) (Bologa et al., 2006), and it may take longer for G-1 to 
activate ERK than E2. Therefore, we included the 15 and 30 min time points as well 
as 5 min time point. However, G-1 infusion did not alter ERK activation at any time 
point. This finding is consistent with data from vascular smooth muscle cells showing 
that E2, but not GPER, increases ERK phosphorylation in these cells (Ortmann et al., 
2011).   
 To further explore possible effects of G-1 on ERK signaling, we measured 
whether G-1 regulated activation of PI3K and Akt, based on our previous finding that 
phosphorylation of PI3K/Akt signaling is necessary for E2 to activate ERK in the DH 
and enhance OR memory consolidation (Fan et al., 2010; Fortress et al., 2013b). 
Moreover, several studies show that GPER can regulate Akt cell signaling in 
numerous cell lines (Moriarty et al., 2006; Maggiolini and Picard, 2010) and in rats 
(Jang et al., 2013). As with ERK, however, we found that DH infusion of G-1 did not 
increase PI3K or Akt phosphorylation at any time point. Indeed, Akt phosphorylation 
was decreased 30 min after infusion, the reason for which is unclear. Nevertheless, the 
fact that G-1 did not increase PI3K and Akt phosphorylation in the DH as observed 
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after E2 infusion indicates that G-1 does not activate multiple aspects of ERK 
signaling in the female mouse DH.  
These data led us to hypothesize that ERK activation would not play a role in 
the ability of G-1 to enhance OR and OP memory consolidation. Consistent with this 
hypothesis, we found that the ERK inhibitor U0126 did not prevent G-1 from 
enhancing OR or OP memory consolidation. These results demonstrate for the first 
time that ERK activation is not necessary for GPER to enhance hippocampal memory 
consolidation in female mice. Although this finding is novel as it relates to memory, it 
is consistent with reports from peripheral tissues showing that the ERK inhibitors 
U0126 and PD98059 do not prevent G-1 from inducing endothelium-dependent 
vasorelaxation in rat aorta (Jang et al., 2013) or DNA synthesis in human epithelial 
cells (Holm et al., 2011). These few examples do not permit any general conclusions 
about the role of ERK in mediating the cellular effects of GPER activation, the 
present data provide evidence that ERK is not involved GPER-mediated memory 
regulation. 
 
The role of JNK in GPER-mediated memory enhancement 
 Given the unexpected lack of a role for ERK in GPER-induced memory 
enhancement, we next sought to identify other signaling pathways through which 
GPER may mediate memory consolidation. We focused on JNK signaling, since this 
MAPK is activated by various G proteins (Goldsmith and Dhanasekaran, 2007) and is 
involved in regulating synaptic plasticity (Tararuk et al., 2006; Waetzig et al., 2006; 
Kim et al., 2007). We demonstrated that GPER activation led to rapid phosphorylation 
of both JNK isoforms in the DH, an effect that was blocked by DH infusino of the 
JNK inhibitor SP600125, but not the ERK inhibitor U0126. In addition, we found that 
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G-1 increased phosphorylation of the downstream JNK transcription factor ATF2, 
suggesting that the G-1 induced phosphorylation of JNK also activated nuclear 
transcription. Importantly, we found that activation of JNK, but not ERK, in the DH is 
necessary for GPER to faciliate memory consolidaion in both the OR and OP tasks. 
As such, these data demonstrate that JNK activation, but not ERK activation, is 
necessary for GPER enhance hippocampal memory consolidation.  
Although JNK has been studied in the context of cellular stress and apoptosis 
(Kyriakis and Avruch, 2001; Reinecke et al., 2013), JNK has also been shown to play 
an important role in synaptic plasticity, neuronal regeneration, and development in the 
central nervous system (Tararuk et al., 2006; Waetzig et al., 2006). However, its role 
in learning and memory has been understudied, and existing data provide conflicting 
results. For example, some studies suggest an important role of JNK activation in 
long-term inhibitory avoidance memory and in short-term synaptic plasticity and 
long-term depression (Bevilaqua et al., 2007; Li et al., 2007; Carboni et al., 2008). 
However, other data indicate that JNK negatively regulates short-term memory in the 
hippocampus (Bevilaqua et al., 2003). Duration of JNK activation may play an 
important role in the resulting effects on memory, as suggested by data showing that 
short-term JNK activation facilitates hippocampal memory and synaptic plasticity, 
whereas prolonged JNK activation leads to memory deficits and neurodegeneration 
(Sherrin et al., 2011). Although our findings cannot directly speak to the 
inconsitencies in the JNK literature, our findings provide much needed additional 
information on the role of JNK in hippocampal memory. These data suggest that JNK 
is an essential mediator of GPER-induced memory modulation. However, as will be 
discussed below, JNK appears to play no role in E2-induced memory modulation.   
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The estrogen receptor that doesn't act like an estrogen receptor 
 Evidence that GPER is an estrogen receptor comes from data showing that E2 
binds GPER with high affinity (Revankar et al., 2005; Moriarty et al., 2006; Prossnitz 
et al., 2007). However, other studies suggest that GPER acts independently of E2. For 
example, a study using endothelial cells from ERα/ERβ-deficient mice demonstrated 
that E2 could not activate cAMP or ERK pathways, despite the presence of GPER 
(Pedram et al., 2006) and cells, COS-7 and CHO (Chinese hamster ovary) cells, 
transfected with GPER failed to signal in response to E2 (Otto et al., 2008). Another 
study revealed that treatment with G-15 or downregulation of GPER expression with 
GPER shRNA did not prevent E2-mediated apoptosis in rat aortic vascular endothelial 
cells (Ding et al., 2014). Further, rapid extranuclear E2 signaling in breast cancer cells 
involved only ERα and ERβ but not GPER (Madak-Erdogan et al., 2008), and the 
neuroprotective effects of E2 on post ischemic injury are not dependent on GPER 
(Lamprecht and Morrison, 2014). Moreover, some investigators insist that GPER is 
not a true ER, but potentially has a collaborative role in mediating the biological 
actions of estrogens (Levin, 2009). Such studies have stimulated extensive debate 
about whether GPER acts as a true estrogen receptor (Langer et al., 2010).  
 The present study adds to the debate by showing that GPER and E2 do not 
enhance memory via the same cell signaling mechanisms. As we have previously 
shown, E2 and agonists of ERα and ERβ require ERK activation in the DH to enhance 
OR and OP memory consolidation in ovariectomized female mice (Fernandez et al., 
2008; Boulware et al., 2013; Fortress et al., 2013b). However, the present study found 
no role of ERK in the memory-enhancing effects of GPER. Furthermore, the present 
study found that E2 did not phosphorylate either isoform of JNK at any time point 
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examined, nor did the JNK inhibitor SP600125 prevent E2 from enhancing OR or OP 
memory consolidation. These data demonstrate not only that E2 does not activate JNK 
in the DH, but also that JNK activation is not necessary for E2 to enhance 
hippocampal memory consolidation. Although these data provide strong support that 
GPER and E2 independently regulate memory formation, more definitive evidence 
comes from the fact that G-15 does not prevent E2 from enhancing either OR or OP 
memory consolidation. These data demonstrate that GPER activation is not necessary 
for E2 to enhance hippocampal memory consolidation, and suggest that GPER does 
not function as an estrogen receptor in the dorsal hippocampus.  Although we cannot 
presently rule out potential interactions between GPER and ERα or ERβ, we find this 
possibility unlikely given how closely ER agonists mimic the effects of E2 on memory 
and ERK signaling (Boulware et al., 2013).  
 
Further studies and conclusion 
The surprising finding that GPER does not act as an estrogen receptor in the 
dorsal hippocampus begs the question of whether GPER directly interacts with ERα 
or ERβ. On the basis of our data, we could first hypothesize that no such interactions 
take place and that GPER is not an estrogen receptor, at least in the hippocampus. If 
GPER does not work as estrogen receptor, the alternative natural ligand for GPER 
might be aldosterone. Some studies have indicated that the potential role of 
aldosterone in GPER activation in vascular smooth muscle cells (Brailoiu et al., 2013; 
Gros et al., 2013), still it needs further investigation (Filardo and Thomas, 2012). 
Although several studies assert that GPER acts independently of E2 (Pedram et al., 
2006; Otto et al., 2008; Ding et al., 2014), it is difficult to ignore the many other 
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studies showing that E2 activates GPER (Revankar et al., 2005; Thomas et al., 2005; 
Moriarty et al., 2006; Prossnitz et al., 2007; Langer et al., 2010). Therefore, an 
alternative hypothesis is that the activation of intracellular ERs may inhibit GPER 
activation. Thus, activation of either ERα or ERβ might be able to suppress GPER 
activation because E2 has higher binding affinity on ERα and ERβ than GPER; 
competitive radiometric binding assay showed the Kd value of E2 on ERα (0.30 nM) 
and ERβ (0.90 nM) in human endometrial cancer (HEC-1) cells, and the Kd value of 
E2 on GPER (3.0 nM) in human embryonic kidney (HEK)293 cells (Sun et al., 1999; 
Thomas et al., 2005). To examine potential interactions between intracellular ERs and 
GPER, we may be able to test whether ERα and ERβ antagonists block the effects of 
G-1 on memory and JNK activation. We can also examine physical interactions 
among the receptors using sucrose fractionation and co-immunoprecipitation (CoIP) 
as we have described previously(Boulware et al., 2013) . Delineating such interactions 
would provide important insight into how the intracellular ERs and GPER may 
interact to regulate hippocampal memory.  
Future studies could also better elucidate the role of JNK signaling in 
hippocampal formation, based on our findings that GPER activation enhances 
hippocampal memory via the JNK signaling pathway. Given how little is known 
about the role of JNK in memory, one possible future direction would be to determine 
the molecular mechanisms through which JNK affects hippocampal memory. Two 
avenues of research may be particularly promising: 1) determining how JNK regulates 
PSD-95 protein, and 2) identifying how JNK modulates gene expression. Because 
interactions between GPER and PSD-95 have been identified in hippocampal 
dendritic spines (Akama et al., 2013) and JNK kinase activity is involved in the 
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regulation of the PSD-95 to recruit synaptic AMPA receptors (Kim et al., 2007), the 
JNK-PSD-95 relationship is worthy of further study to elucidate how JNK affects 
hippocampal memory. Physical interaction between JNK and PSD-95 can be 
examined by Co-IP and JNK inhibition effect on PSD-95 expression can be tested by 
western blot or PCR. JNK-mediated gene expression in the hippocampus would also 
be interesting to examine because we showed that G-1 activated the JNK downstream 
transcription factor, ATF-2. ATF-2 works as a transcription factor responding to nerve 
growth factor in sympathetic neurons (Lau and Ronai, 2012), therefore, microarray 
technique will provide potential target gene for ATF-2 in the hippocampus and the 
gene expression will be confirmed by RT-PCR. If we find JNK-mediated changes in 
gene expression, then it would be interesting to examine the epigenetic processes that 
might regulate this expression. For example, our laboratory has demonstrated that 
histone acetylation and DNA methylation are necessary for E2 to enhance OR memory 
consolidation in ovariectomized female mice (Zhao et al., 2010; Zhao et al., 2012). In 
addition, E2-induced histone H3 acetylation was dependent on ERK activation (Zhao 
et al., 2010; Zhao et al., 2012), indicating that changes in histone acetylation are 
triggered by cell signaling mechanisms. To our knowledge, JNK-induced regulation 
of epigenetic processes has not been investigated, and so is an area ripe for 
investigation.  
 In conclusion, the present study provides the first evidence that GPER 
activation can enhance hippocampal memory consolidation in JNK dependent manner 
and that E2-mediated memory enhancement is independent of GPER and JNK 
activation. These results do not support a role for GPER in the memory-enhancing 
effects of E2, although GPER activation has similar memory-enhancing effects as E2. 
This interesting finding may have important implications for the future design of 
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estrogen-based therapies for reducing the risk of age-related memory decline and 
Alzheimer’s disease in women (Yaffe et al., 1998; Zandi et al., 2002). Therefore, 
better understanding of GPER function could provide important opportunities for the 
development of new therapies that would provide the cognitive benefits of estrogen 
without potentially dangerous side effects. 
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